Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
MEDICLIN Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2.58 |
52 Week High | €2.58 |
52 Week Low | €2.58 |
Beta | 0.26 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -26.66% |
Recent News & Updates
Recent updates
Shareholder Returns
0NDG | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | 1.4% | -1.3% |
1Y | n/a | -15.0% | 8.9% |
Return vs Industry: Insufficient data to determine how 0NDG performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how 0NDG performed against the UK Market.
Price Volatility
0NDG volatility | |
---|---|
0NDG Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 9.5% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NDG's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0NDG's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 6,910 | Joachim Ramming | www.mediclin.de |
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others.
MEDICLIN Aktiengesellschaft Fundamentals Summary
0NDG fundamental statistics | |
---|---|
Market cap | €113.05m |
Earnings (TTM) | -€14.95m |
Revenue (TTM) | €764.10m |
0.1x
P/S Ratio-7.6x
P/E RatioIs 0NDG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0NDG income statement (TTM) | |
---|---|
Revenue | €764.10m |
Cost of Revenue | €618.32m |
Gross Profit | €145.78m |
Other Expenses | €160.73m |
Earnings | -€14.95m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 04, 2024
Earnings per share (EPS) | -0.31 |
Gross Margin | 19.08% |
Net Profit Margin | -1.96% |
Debt/Equity Ratio | 46.7% |
How did 0NDG perform over the long term?
See historical performance and comparison